Understanding CARdiac Events in Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-90
SponsorNational University of Ireland, Galway, Ireland
About this trial
In Ireland, over 3,000 patients are diagnosed with breast cancer annually, and 1 in 9 Irish women will be diagnosed with breast cancer in their lifetime. There is evidence that female breast cancer survivors are more likely to die of cardiovascular disease than their age-matched counterparts.
This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment. The Cardio-oncology research team at GUH plan to capitalize on their expertise in both cancer care and cardiology to develop a care pathway for cancer patients who are at increased risk of developing heart disease.
Eligibility criteria
Qualifiers
Women aged ≥ 18 years
Ability to read and understand English
Breast Cancer Stage I- III planned to receive systemic chemotherapy
Disqualifiers
Patients not for systemic chemotherapy with curative intent
Patients who are unable to co-operate with the study protocol
Patients who are unable to give informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 4 trial groupsSponsors and collaborators
National University of Ireland, Galway, Ireland
Lead sponsor
HRB Clinical Research Facility Galway
Collaborator
CORRIB Research Centre for Advanced Imaging and Core Lab, Galway, Ireland
Collaborator
Source ClinicalTrials.gov